Features of post-infarction chronic heart failure in patients with a new coronavirus infection COVID-19

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


Background. The coronavirus pandemic has caused a rapid increase in the number of cases and high deaths worldwide. A new coronavirus infection in the presence of an initial cardiac pathology can provoke decompensation of chronic heart failure.

Aim. To study the clinical features of postinfarction chronic heart failure occurring against the background of a new coronavirus infection.

Material and methods. The study included 80 patients with decompensated chronic heart failure. Three groups have been formed. In patients of the first group (n=40), who underwent inpatient treatment for a new coronavirus infection, the cause of chronic heart failure was a previous Q-myocardial infarction. In patients of the second group (n=20), who did not tolerate COVID-19 earlier and at the time of the current hospitalization, the cause of chronic heart failure was a previous Q-myocardial infarction. The third group (n=20) consisted of patients with chronic heart failure of ischemic etiology without postinfarction cardiosclerosis, not previously and at the time of examination infected with the SARS-Cov-2 virus. Statistical analysis was carried out using the IBM SPSS Statistics V26 program. The Kolmogorov–Smirnov, Kruskal–Wallis, and Pearson χ2 tests were used.

Results. Symptoms of left and right ventricular heart failure were equally common in all groups. Patients of the studied groups had a history of paroxysmal and permanent forms of atrial fibrillation, while the latter variant was more common in patients of the first group — with chronic heart failure with postinfarction cardiosclerosis and coronavirus infection. According to echocardiography, the most pronounced structural and functional changes in the myocardium were also found in patients of the first group with postinfarction heart failure and a new coronavirus infection. Thus, statistically significant differences related to the size of the left atrium, end diastolic volume and end systolic volume of the left ventricle, systolic pressure in the pulmonary artery. An increase in the end systolic volume of the left ventricle by 94.6% was registered in the first group compared with the third group of patients (p=0.001). Systolic pressure in the pulmonary artery in the first group was 14.2% higher than the normal values (p ≤0.001), while in patients of the second and third groups this indicator was within the normal range.

Conclusion. In patients with postinfarction cardiosclerosis suffering from a new coronavirus infection, symptoms of chronic heart failure are more pronounced, characterized by a significant decrease in exercise tolerance; cardiac arrhythmias are more often recorded, and structural and functional changes in the myocardium are of a maladaptive nature.

Full Text

Restricted Access

About the authors

Natalya M. Kalashnikova

Chita State Medical Academy

Author for correspondence.
Email: natka.kalashnikova@mail.ru
ORCID iD: 0000-0002-1283-7938

PhD Stud., Depart. of Faculty Therapy

Russian Federation, Chita, Russia

Dmitriy N. Zaitsev

Chita State Medical Academy

Email: zaycevdn@mail.ru
ORCID iD: 0000-0002-2741-3783

M.D., D. Sci. (Med.), Assoc. Prof., Head of the Depart., Depart. of Faculty Therapy, Rector

Russian Federation, Chita, Russia

Anatoly V. Govorin

Chita State Medical Academy

Email: govorav@mail.ru
ORCID iD: 0000-0001-7586-6595

M.D., D. Sci. (Med.), Prof., Leading Specialist in Scientific Work, Scientific Department

Russian Federation, Chita, Russia

Natalya V. Mukha

Chita State Medical Academy

Email: mushanatasha@inbox.ru
ORCID iD: 0000-0001-8128-636X

M.D., Cand. Sci. (Med.), Assoc. Prof., Depart. of Faculty Therapy

Russian Federation, Chita, Russia

Marina V. Chistyakova

Chita State Medical Academy

Email: m.44444@yandex.ru
ORCID iD: 0000-0001-6280-0757

M.D., D. Sci. (Med.), Prof., Depart. of Functional and Ultrasound Diagnostics

Russian Federation, Chita, Russia


  1. Braunwald E. The war against heart failure: the Lancet lecture. Lancet. 2015;385:812–824. doi: 10.1016/S0140-6736(14)61889-4.
  2. Residual confounding in observational studies: New data from the old DIG Trial. Eur Heart J. 2019;40(40):3342–3344. doi: 10.1093/eurheartj/ehz527.
  3. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200. doi: 10.1093/eurheartj/ehw128.
  4. Mareev VYu, Fomin IV, Ageev FT, Begrambekova YuL, Vasyuk YuA, Garganeeva AA, Gendlin GE, Glezer MG, Gautier SV, Dovzhenko TV, Kobalava ZD, Koziolova NA, Koroteev AV, Mareev YuV, Ovchinnikov AG, Perepech NB, Tarlovskaya EI, Chesnikova AI, Shevchenko AO, Arutyunov GP, Belenkov YuN, Galyavich AS, Gilyarevsky SR, Drapkina OM, Duplyakov DV, Lopatin YuM, Sitnikova MYu, Skibitsky VV, Shlyakhto EV. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for heart fai-lure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;58(6S):8–158. (In Russ.) doi: 10.18087/cardio.2475.
  5. Fomin IV. Chronic heart failure in Russian Federation: What do we know and what to do. Russian Journal Of Cardiology. 2016;(8):7–13. (In Russ.) doi: 10.15829/1560-4071-2016-8-7-13.
  6. Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, Madhur MS, Tomaszewski M, Maffia P, D’Acquisto F, Nicklin SA, Marian AJ, Nosalski R, Murray EC, Guzik B, Berry C, Touyz RM, Kreutz R, Wang DW, Bhella D, Sagliocco O, Crea F, Thomson EC, McInnes IB. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666–1687. doi: 10.1093/cvr/cvaa106.
  7. Kievit RF, Gohar A, Hoes AW, Bots ML, van Riet EE, van Mourik Y, Bertens LC, Boonman-de Winter LJ, den Ruijter HM, Rutten FH; Queen of Hearts and RECONNECT consortium. Efficient selective screening for heart failure in elderly men and women from the community: A diagnostic individual participant data meta-analysis. Eur J Prev Cardiol. 2018;25(4):437–446. doi: 10.1177/2047487317749897.
  8. Mitkovskaya NP, Petrova EB. Abdominal obesity in the development of chronic heart failure after myocardial infarction. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2017;(4):86–92. (In Russ.)
  9. Bui A, Horwich T, Fonarow G. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8(1):30–41. doi: 10.1038/nrcardio.2010.165.
  10. Polyakov DS, Fomin IV, Valikulova FYu, Weisberg AR, Kraiem N, Badin YuV, Shcherbinina EV, Ivanchenko EYu. The EPOCH-CHF epidemiological program: decompensated chronic heart failure in real-life clinical practice (EPOCH-D-CHF). Russian heart failure journal. 2016;17(5):299–305. (In Russ.) doi: 10.18087/RHFJ.2016.5.2239.
  11. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report-48. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.pdf?sfvrsn=16f7ccef_4 (access date: 29.08.2022).
  12. Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017–1032. doi: 10.1038/s41591-020-0968-3.
  13. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospita-lized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585.
  14. Ezekowitz JA, Bakal JA, Kaul P, Westerhout CM, Armstrong PW. Acute heart failure in the emergency department: short and long-term outcomes of elderly patients with heart failure. Eur J Heart Fail. 2008;10(3):308–314. doi: 10.1016/j.ejheart.2008.01.014.
  15. Huffman MD, Roth GA, Sliwa K, Yancy CW, Prabhakaran D. Cardiovascular, respiratory, and related disorders. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development/The World Bank; 2017. Chapter 10. https://www.ncbi.nlm.nih.gov/books/NBK525153/ (access date: 29.09.2022).
  16. Chistyakova MV, Zaytsev DN, Govorin AV, Goncharova EV, Kalinkina TV, Medvedeva NA. Morpho-functional changes and cardiac arrhythmias in patients with mild to moderate coronavirus infection (COVID-19). Zabaykalskiy meditsinskiy vestnik. 2021;(2):76–84. (In Russ.) doi: 10.52485/19986173_2021_2_76.
  17. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
  18. King KC, Goldstein S. Congestive heart failure and pulmonary edema. [Updated 2021 Sep. 1]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK554557/ (access date: 29.09.2022).
  19. Guidelines MP 3.1.0169-20 (as amended by MP 3.1.0174-20 “Changes No. 1 in MP 3.1.0170-20 “Laboratory diagnostics of COVID-19”). Approved by Rospotrebnadzor on 04/30/2020. https://www.rospotrebnadzor.ru/files/news/%D0%BC%D1%80%203.1.0174-20.pdf (access date: 29.08.2022). (In Russ.)

Supplementary files

Supplementary Files
1. Рис. 1. Функциональный класс (ФК) хронической сердечной недостаточности у пациентов исследуемых групп

Download (16KB)

© 2023 Eco-Vector

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies